Literature DB >> 6404636

Effect of activated charcoal on absorption of tolbutamide and valproate in man.

P J Neuvonen, H Kannisto, E L Hirvisalo.   

Abstract

The claim that activated charcoal should be ineffective or even contraindicated in intoxication due to tolbutamide is based only on limited in vitro studies. To test the claim, the effect of activated charcoal 50 g on the absorption of tolbutamide and, as a reference, of sodium valproate, was studied in 6 healthy volunteers. Each volunteer swallowed tolbutamide 500 mg and sodium valproate 300 mg with 50 ml water 1 h after a light breakfast, and within 5 min they took in randomized order either a suspension of activated charcoal or water. The absorption of tolbutamide, calculated as the peak concentration and the area under the serum drug concentration-time curve during 0-48 h, was reduced by 90% by charcoal (p less than 0.001). The absorption of valproate in these conditions was reduced on average by 65% (p less than 0.01). In each subject charcoal had a greater effect on the absorption of tolbutamide than of valproate. According to these findings and preliminary in vitro studies on other sulphonylureas high doses of activated charcoal can be recommended for the preventing the absorption of sulphonylureas in acute intoxications. The poor aqueous solubility of these substances at the gastric pH probably delays their gastrointestinal absorption, so that they may be adsorbed on to charcoal even given several hours later.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404636     DOI: 10.1007/BF00613825

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  THE BLACK BOTTLE. A CONSIDERATION OF THE ROLE OF CHARCOAL IN THE TREATMENT OF POISONING IN CHILDREN.

Authors:  L E HOLT; P H HOLZ
Journal:  J Pediatr       Date:  1963-08       Impact factor: 4.406

2.  Experimental studies on the pharmacology of activated charcoal; the effect of pH on the adsorption by charcoal from aqueous solutions.

Authors:  A H ANDERSEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1947

Review 3.  Use of activated charcoal in acute poisoning.

Authors:  J W Hayden; E G Comstock
Journal:  Clin Toxicol       Date:  1975       Impact factor: 4.467

4.  Adsorption of drugs and poisons by activated charcoal.

Authors:  W J Decker; H F Combs; D G Corby
Journal:  Toxicol Appl Pharmacol       Date:  1968-11       Impact factor: 4.219

5.  Inhibition of aspirin absorption by activated charcoal and apomorphine.

Authors:  W J Decker; R A Shpall; D G Corby; H F Combs; C E Payne
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

6.  Medicoal (effervescent activated charcoal) in the treatment of acute poisoning.

Authors: 
Journal:  Drug Ther Bull       Date:  1979-01-19

7.  High-performance liquid chromatographic assay of tolbutamide and carboxytolbutamide in human plasma.

Authors:  G Raghow; M C Meyer
Journal:  J Pharm Sci       Date:  1981-10       Impact factor: 3.534

8.  Gastric aspiration and lavage in acute poisoning.

Authors:  H Matthew; T F Mackintosh; S L Tompsett; J C Cameron
Journal:  Br Med J       Date:  1966-05-28

9.  Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.

Authors:  P J Neuvonen; S M Elfving; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

10.  Comparison of activated charcoal and ipecac syrup in prevention of drug absorption.

Authors:  P J Neuvonen; M Vartiainen; O Tokola
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more
  7 in total

1.  Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  The effect of cholestyramine and activated charcoal on glipizide absorption.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

Review 3.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Influence of enterohepatic recycling on the time course of brain-to-blood partitioning of valproic acid in rats.

Authors:  Jeannie M Padowski; Gary M Pollack
Journal:  Drug Metab Dispos       Date:  2012-06-19       Impact factor: 3.922

Review 5.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

Review 6.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

7.  All guns blazing: management and survival of massive valproic acid overdose - case report and literature review.

Authors:  Shaikha Al Jawder; Eiman AlJishi; Shaikhah Al-Otaibi; Mohammed S Al-Shahrani
Journal:  Open Access Emerg Med       Date:  2018-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.